We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

TechNet MassSpec EdCal 25thJan2024

Mass Spectrometry-Based Omics Strategies for Biomarker Discovery in Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population.  While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking. To address this challenge and uncover the diverse molecular signatures associated with disease progression, researchers are developing mass spectrometry based omics strategies to obtain a chemical atlas in biofluids collected from AD patients and tissue samples.

Dr. Lingjun Li from the University of Wisconsin-Madison will introduce multiplexed chemical tagging strategies to discover, identify and evaluate candidate biomarkers of AD in CSFs to elucidate disease progression and create a detailed biomolecular atlas of the brain of AD. 

Attend this webinar to:

  • Learn how to use systems biology omics strategies to probe protein and peptide dynamic changes in AD
  • Learn the design and application of chemical tagging approach for multiplex quantitation
  • Learn the basic workflow of spatial omics approach enabled by MALDI mass spectrometry imaging

A picture of Dr. Lingjun Li
Dr. Lingjun Li
Professor of Pharmaceutical Sciences and Chemistry, School of Pharmacy and Department of Chemistry
University of Wisconsin-Madison
Sponsored by

Interested in sponsoring this webinar? Contact our friendly sales team here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar